|
|
 |
|
Viewing report
|
|
|
|
Protein-Protein Interactions as Drug Targets- Focusing On Cell Circuitry
Drug and Market Development Publishing, Jan 2005
The area of protein-protein interaction has been growing at a tremendous rate. The market is expected to reach over $50 billion by year 2010. Protein-protein interaction targeting activities are increasing and are expected to bring success in the near future. Protein-protein interactions are critical for normal and tumor cells signal transduction pathways, making them attractive targets for developing therapeutic molecules.Targeting protein-protein interactions has been challenging due to the diversity and complexity of proteins involved and the structures they form. However, the number of therapeutic molecules that have been developed against signal transduction proteins that are involved in protein-protein interactions is increasing at a steady rate.Key Reasons to Buy this report:- Step by step guidance into the challenges and opportunities associated with exploring PPI as targets.- Receive a clear understanding of the role PPI plays in signal transduction and big market human diseases such as cancer, diabetes, and obesity.- In depth analysis of emerging growth areas by targeting PPI.- Latest developments in the identification and screening of small molecules, peptides, and antibodies that target PPI.- Interviews with key industry leaders within this space.
Customers who bought this item also bought
Protein-Protein Interactions: Are They Now Druggable Targets?
Mass Spectrometry of Protein Interactions
Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets
European Protein Purification Markets
Global Protein Therapeutics Market Analysis
Mass Spectrometry Analysis for Protein-Protein Interactions and Dynamics
Biochemistry of Signal Transduction and Regulation, 4th Edition
The Global Protein Therapeutics Market
Protein Ingredients - Global Strategic Business Report
G Protein-coupled Receptors: Molecular Pharmacology
Innovations in Protein Kinase Therapies: Company Pipelines, Therapeutic Applications and Market Forecasts
Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors
|
|
|
|
